Title:
CANCER ASSOCIATED ANTIGENS
Document Type and Number:
WIPO Patent Application WO/2005/108420
Kind Code:
A1
Abstract:
The invention relates to isolated nucleic acid sequences which are expressed in cancers, especially gastrointestinal, kidney and prostate cancers, to their protein products and to the use of the nucleic acid and protein products for the identification and treatment of cancers.
More Like This:
| JP2022521591 | Treatment of kidney damage |
| WO/2017/085115 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING RHABDOMYOLYSIS |
| WO/2011/110683 | GLCE AS A TARGET FOR ANTI-TUMOUR THERAPY |
Inventors:
REES ROBERT CHARLES (GB)
MILES AMANDA KATHLEEN (GB)
LI GENG (GB)
MILES AMANDA KATHLEEN (GB)
LI GENG (GB)
Application Number:
PCT/GB2005/001197
Publication Date:
November 17, 2005
Filing Date:
March 24, 2005
Export Citation:
Assignee:
UNIV NOTTINGHAM TRENT (GB)
REES ROBERT CHARLES (GB)
MILES AMANDA KATHLEEN (GB)
LI GENG (GB)
REES ROBERT CHARLES (GB)
MILES AMANDA KATHLEEN (GB)
LI GENG (GB)
International Classes:
A61K31/713; A61K38/17; A61K39/00; A61P35/00; C07K14/47; C07K16/30; C12N15/12; C12Q1/68; G01N33/574; G01N33/68; A61K38/00; (IPC1-7): C07K14/47; C12N15/12; C12Q1/68; G01N33/68; A61P35/00; A61K31/713; A61K38/17; A61K39/00
Domestic Patent References:
| WO2001053312A1 | 2001-07-26 |
Other References:
DATABASE EMBL [online] 24 March 2003 (2003-03-24), "Homo sapiens sarcoma antigen NY-SAR-27 mRNA, partial cds.", XP002336240, retrieved from EBI accession no. EM_PRO:AY211915 Database accession no. AY211915
DATABASE EMBL [online] 22 February 2000 (2000-02-22), "Homo sapiens cDNA FLJ10330 fis, clone NT2RM2000624, weakly similar to SPLICING FACTOR, ARGININE/SERINE-RICH 4.", XP002336241, retrieved from EBI accession no. EM_PRO:AK001192 Database accession no. AK001192
DATABASE Geneseq [online] 8 February 2001 (2001-02-08), "Human ORFX ORF2399 polypeptide sequence SEQ ID NO:4798.", XP002336285, retrieved from EBI accession no. GSP:AAB42635 Database accession no. AAB42635
DATABASE EPO Proteins [online] 17 December 2003 (2003-12-17), "Sequence 11104 from Patent EP1074617.", XP002336286, retrieved from EBI accession no. EPOP:AX876199 Database accession no. AX876199
DATABASE Geneseq [online] 22 April 2004 (2004-04-22), "Human protein that promotes STAT6 activation #15.", XP002336287, retrieved from EBI accession no. GSP:ADI26065 Database accession no. ADI26065
DATABASE JPO Proteins [online] 17 June 2003 (2003-06-17), "STAT6 activating gene.", XP002336288, retrieved from EBI accession no. JPOP:BD587825 Database accession no. BD587825
MILES AMANDA ET AL: "Expression analysis of prostate-associated tumor antigens identified via a modified SEREX approach.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 44, July 2003 (2003-07-01), & 94TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH; WASHINGTON, DC, USA; JULY 11-14, 2003, pages 358 - 359, XP001207011, ISSN: 0197-016X
DATABASE EMBL [online] 22 February 2000 (2000-02-22), "Homo sapiens cDNA FLJ10330 fis, clone NT2RM2000624, weakly similar to SPLICING FACTOR, ARGININE/SERINE-RICH 4.", XP002336241, retrieved from EBI accession no. EM_PRO:AK001192 Database accession no. AK001192
DATABASE Geneseq [online] 8 February 2001 (2001-02-08), "Human ORFX ORF2399 polypeptide sequence SEQ ID NO:4798.", XP002336285, retrieved from EBI accession no. GSP:AAB42635 Database accession no. AAB42635
DATABASE EPO Proteins [online] 17 December 2003 (2003-12-17), "Sequence 11104 from Patent EP1074617.", XP002336286, retrieved from EBI accession no. EPOP:AX876199 Database accession no. AX876199
DATABASE Geneseq [online] 22 April 2004 (2004-04-22), "Human protein that promotes STAT6 activation #15.", XP002336287, retrieved from EBI accession no. GSP:ADI26065 Database accession no. ADI26065
DATABASE JPO Proteins [online] 17 June 2003 (2003-06-17), "STAT6 activating gene.", XP002336288, retrieved from EBI accession no. JPOP:BD587825 Database accession no. BD587825
MILES AMANDA ET AL: "Expression analysis of prostate-associated tumor antigens identified via a modified SEREX approach.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 44, July 2003 (2003-07-01), & 94TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH; WASHINGTON, DC, USA; JULY 11-14, 2003, pages 358 - 359, XP001207011, ISSN: 0197-016X
Attorney, Agent or Firm:
Elsy, David (Goldings House 2 Hays Lane, London SE1 2HW, GB)
Download PDF:
Previous Patent: MUTANT CHOLESTEROL-BINDING CYTOLYSIN PROTEINS
Next Patent: AMMONIUM/AMMONIA TRANSPORTER
Next Patent: AMMONIUM/AMMONIA TRANSPORTER